Literature DB >> 11739298

Thrombolysis in pulmonary embolism: a large-scale clinical trial is overdue.

S Z Goldhaber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11739298

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  6 in total

1.  Systemic thrombolysis in acute pulmonary embolism: also a matter of "time".

Authors:  Marco Zuin; Loris Roncon
Journal:  J Thromb Thrombolysis       Date:  2017-02       Impact factor: 2.300

2.  Biomarker-based strategy for screening right ventricular dysfunction in patients with non-massive pulmonary embolism.

Authors:  Damien Logeart; Lucien Lecuyer; Gabriel Thabut; Jean-Yves Tabet; Jean-Michel Tartière; Christophe Chavelas; François Bonnin; Jean-Louis Stievenart; Alain Cohen Solal
Journal:  Intensive Care Med       Date:  2006-12-13       Impact factor: 17.440

3.  [Therapeutic approaches to acute pulmonary embolism].

Authors:  A Reissig; C Kroegel
Journal:  Internist (Berl)       Date:  2004-05       Impact factor: 0.743

4.  Enlarged right ventricle without shock in acute pulmonary embolism: prognosis.

Authors:  Paul D Stein; Afzal Beemath; Fadi Matta; Lawrence R Goodman; John G Weg; Charles A Hales; Russell D Hull; Kenneth V Leeper; H Dirk Sostman; Pamela K Woodard
Journal:  Am J Med       Date:  2008-01       Impact factor: 4.965

5.  Thrombolytic-plus-Anticoagulant Therapy versus Anticoagulant-Alone Therapy in Submassive Pulmonary Thromboembolism (TVASPE Study): A Randomized Clinical Trial.

Authors:  Maryam Taherkhani; Adineh Taherkhani; Seyed Reza Hashemi; Taraneh Faghihi Langroodi; Roxana Sadeghi; Mohammadreza Beyranvand
Journal:  J Tehran Heart Cent       Date:  2014-07-03

6.  Management of massive and nonmassive pulmonary embolism.

Authors:  Vishal Sekhri; Nimeshkumar Mehta; Naveen Rawat; Stuart G Lehrman; Wilbert S Aronow
Journal:  Arch Med Sci       Date:  2012-12-19       Impact factor: 3.318
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.